Clinical Trial Update: Different Dose of Intravenous Omeprazole to Treat Bleeding Ulcer With Adherent Clot [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated different doses of intravenous omeprazole to treat bleeding peptic ulcers with adherent clots.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Hemorrhage
• Peptic Ulcer Disease

Drugs mentioned

• Omeprazole (Omeprazole)

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Peptic Ulcer, Hemorrhage | Phase 4 | Status: COMPLETED